Lobbying

Pointclickcare Technologies's latest lobbying report covers Q2 2026, at $120K. The four quarters Q4 2025–Q3 2026 total $350K. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Pointclickcare Technologies

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$350K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Pointclickcare Technologies lobbying by quarter
Pointclickcare Technologies lobbying by quarter
QuarterAmountReports
Q4 2022$120K2
Q1 2023$120K2
Q2 2023$120K2
Q3 2023$120K2
Q4 2023$120K2
Q1 2024$120K2
Q2 2024$120K2
Q3 2024$120K2
Q4 2024$120K2
Q1 2025$120K2
Q2 2025$120K2
Q3 2025$120K2
Q4 2025$120K2
Q1 2026$110K2
Q2 2026$120K2
Q3 2026$00

By issue

  • Health issues$1.8M · 30 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES24 reports
  • SENATE18 reports

Firms it paid

Firm
In-housePointclickcare Technologies USA$1.1M15 quarters
King & Spalding$740K15 quarters

Former officials lobbying for it

Former position
EMILY DUHOVNY SILVERBERGApr 2025-May 2026 Deputy Chief of Staff/LegislativevDirector Jan 2021-Apr 2025 Legislative Director May 2014-Jan 2020 Senior Legislative/Policy Advisor Jan 2013-April 2018 Staff/Legislative Assistant Sep 2012-Jan 2013 Congressional Intern.Q2 2026
TODD TUTENJan 2025-Mar 2026 U.S. Senate Committee on Health, Education, Labor, & Pensions, Chief Counsel May 2025-Mar 2026, Senior Health Counsel Jan 2025-May 2025 [House Lobbying Only]Q2 2026
SCOTT DZIENGELSKIRep. Murphy (PA-18): Leg. Dir. (2015-2017), Sr. Leg. Asst. (2013-2015), Leg. Asst.(2012-2013), Leg. Corr. (2011-2012), Staff Asst. (2010-2011); Energy and Commerce Committee: Staff (2015-2017)Q1 2026

Lobbying reports

Filed by
07/19for Q2King & Spalding$50K
07/10for Q2In-house$70K
04/20for Q1King & Spalding$40K
04/17for Q1In-house$70K
01/19for Q4 2025King & Spalding$50K
01/19for Q4 2025In-house$70K
25/10/19for Q3 2025King & Spalding$50K
25/10/17for Q3 2025In-house$70K
25/07/21for Q2 2025King & Spalding$50K
25/07/17for Q2 2025In-house$70K
25/04/18for Q1 2025In-house$70K
25/04/17for Q1 2025King & Spalding$50K
25/01/14for Q4 2024King & Spalding$50K
25/01/03for Q4 2024In-house$70K
24/10/21for Q3 2024King & Spalding$50K
24/10/17for Q3 2024In-house$70K
24/07/22for Q2 2024In-house$70K
24/07/21for Q2 2024King & Spalding$50K
24/04/19for Q1 2024In-house$70K
24/04/19for Q1 2024King & Spalding$50K